Abstract RF3-02: Gene Expression-based Subtyping of Early Triple-Negative Breast Cancer (TNBC) for Prediction of Response to Neoadjuvant Immune-chemotherapy in the NSABP B-59/GBG-96-GeparDouze Trial
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: C. Denkert, S. Rachakonda, T. Karn, A. Schneeweiss, C. Solbach, P. Rastogi, F. Moreno, T. Freeman, T. Link, J. Mouta, M. Reinisch, R. Meyer, Á. Rodríguez Lescure, V. Bjelic-Radisic, P. A. Fasching, M. Balic, M. Untch, K. Rhiem, J. Teply-Szymanski, K. Lüdtke-Heckenkamp, J. Huober, S. Morales, I. Blancas, J. Holtschmidt, V. Nekljudova, N. Wolmark, C. E. Geyer, S. Loibl
Institutions: Philipps University of Marburg, Universitätsklinikum Gießen und Marburg, German Breast Group, Goethe University Frankfurt, German Cancer Research Center, University Hospital Heidelberg, National Center for Tumor Diseases, University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Hospital Clínico San Carlos, GEICAM – Spanish Breast Cancer Group, University Hospital Carl Gustav Carus, Nationales Centrum für Tumorerkrankungen Dresden, Technische Universität Dresden, Roche (Portugal), Heidelberg University, University Medical Centre Mannheim, Hospital General Universitario de Elche, Witten/Herdecke University, Helios Universitätsklinikum Wuppertal, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen, Helios Kliniken, Helios Hospital Berlin-Buch, University Hospital Cologne, Kantonsspital St. Gallen, Instituto de Investigación Biosanitaria de Granada
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129352207